Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N [2 (7 methoxynaphthalene 1 yl) ethyl] acetamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102942501A details a novel one-pot hydrogenation method for Agomelatine, offering high purity, reduced dimer impurities, and significant cost advantages for pharmaceutical manufacturing.